HOME >> BIOLOGY >> NEWS
Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

UC San Francisco researchers have determined how a protein already strongly associated with colon cancer actually exacts its toll, offering a potential new target for drug therapy.

In their study, published in the April 1 issue of Nature, the investigators report that a protein known as beta catenin gives colon cells the internal nudge they need to circumvent a molecular checkpoint that normally regulates the cycle of cell growth. By evading the checkpoint, known as retinoblastoma (Rb), colon cells proceed to divide uncontrollably and excessively, a hallmark of cancer.

"We've known for several years that colon cancers have high levels of this protein, and that it almost certainly drives the cancer," said the senior author of the study, Frank McCormick, Ph.D., F.R.S., director of the UCSF Cancer Research Institute. "The question has been, `how the heck it does it.'"

A conundrum for researchers has been the fact the retinoblastoma checkpoint remains intact in colon cancer cells.

"Probably every human cancer has a defect in the retinoblastoma checkpoint, and it is this defect that allows cells to grow under conditions that would be forbidden in normal cells," said McCormick. "In colon cancer, it's been known for years that the checkpoint is intact. We've determined that colon cancers have found a way around the checkpoint."

McCormick and Osamu Tetsu, M.D., Ph.D., a visiting postdoctoral fellow in McCormick's lab, determined that beta catenin disrupts cell regulation by synthesizing cyclin D1, a protein that prompts cells to enter S-phase, the point at which a cell duplicates its DNA, in preparation for cell division. "High levels of cyclin D1 override the checkpoint," said McCormick. "This explains how the cells proliferate out of control even though the checkpoint remains intact."

The finding, said McCormick, should fuel ongoing efforts by pharmaceutical companies to develop ways to block beta catenin, which plays a direct causal r
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-Apr-1999


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Protein stops blood-vessel growth, holds promise as cancer therapy
11. Proteins transform DNA into molecular velcro

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
Cached News: